noom semaglutide dosing Microdosing GLP-1 for Weight Loss Noom offers cut-price compounded GLP-1

GLP-1 users typically eat about 21% fewer calories, leading to 1220% body weight loss in 18 months

Any use outside of a formal clinical trial setting would be considered unlicensed and is not endorsed by NICE or NHS guidance

This can depend on how well they follow the right dose, if they change what they eat, and by adding physical activity into their days

For many, GLP-1s can deepen disconnection from hunger cues, reinforce fear of weight gain, and make recovery feel even further out of reach

I promise I cam back

Treatment is available in all 50 states with no insurance requirement, and HSA/FSA accounts are eligible for payment